Aptorum Group Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0TTM through 31 Dec 2025
Net Income -$1.4MTTM through 31 Dec 2025
Free Cash Flow -$1.8MTTM through 31 Dec 2025
Margins
| Current |
|---|
Returns
-5.9%ROE
-7.3%ROA
Balance Sheet Health
Debt / Equity0.14x
Current Ratio0.78x
Net Debt-$124.4Knet cash position
Cash & Equivalents$3.5M
Quality Metrics
Altman Z-Score-5.76
Piotroski F-Score3 / 9
Multi-Year Trend
RevenueFY2023: $431.4K
Diluted EPS-$0.19TTMFY2025: $-0.19
Dividend
No dividend
Capital Allocation
R&D Spend$352.9K
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.